DB-1310

DB-1310 · DualityBio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DB-1310, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DB-1310 in Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]